Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag
Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag, commonly known as Egis, is a prominent pharmaceutical company headquartered in Hungary (HU). Established in 1888, Egis has evolved into a key player in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of generic and innovative medicines. With a strong presence in Central and Eastern Europe, Egis is renowned for its diverse portfolio, which includes prescription drugs, over-the-counter products, and active pharmaceutical ingredients. The company is distinguished by its commitment to quality and innovation, consistently achieving significant milestones in research and development. Egis holds a notable market position, recognised for its contributions to healthcare and its robust pipeline of products that cater to various therapeutic areas. Through its dedication to excellence, Egis continues to enhance patient care and solidify its reputation as a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag's score of 28 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag's reported carbon emissions
Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag, headquartered in Hungary (HU), currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. The company may be in the process of developing its climate strategy or reporting framework, which is common in the pharmaceutical industry as companies increasingly focus on environmental responsibility. Further information on their climate commitments or future targets would be necessary to provide a comprehensive overview of their environmental performance.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
